Injectables for Clinical Trials Specialist Appoints Business Development Manager

Symbiosis Pharmaceutical Services has announced the arrival of Business Development Manager Joanne Anderson, who possesses a background in programme management that has seen her responsible for an R&D portfolio that afforded experience of taking products from research through to commercialisation.

Having worked in analytical chemistry and biomedical analysis roles, Anderson first entered the pharmaceutical industry over 12 years ago with an API manufacturer and was more recently with a fill/finish service provider. Having previously set up a client account management function, she moved into the sales arena while completing a Master’s in Business Administration at Newcastle University Business School.

Anderson will be responsible for securing target sales for new and existing clients through developing relationships and industry networks for penetration of new and existing markets along with representing Symbiosis at trade exhibitions, conferences and partnering events to identify potential new clients and partners.

Colin Mackay, Symbiosis CEO, said: “We are delighted to have Joanne joining the Symbiosis team and her strategic appointment is a key element of the company’s growth plans and her role is central to the development of our commercial operations. Joanne’s energy and experience aligns with the ambitions of the company and strengthens our ability to tailor our services to our clients’ specific sterile manufacturing needs.”

Anderson said: “At the heart of any business are the people and as soon as I met the Symbiosis team I could feel the energy in this dynamic and rapidly developing organisation. The Symbiosis focus on the creation of long-term mutually beneficial relationships aligns strongly with my belief of how service providers can integrate seamlessly as a preferred outsourcing partner.”

Symbiosis Pharmaceutical Services specialises in the GMP manufacture of liquid, lyophilised, cytotoxic, conventional and biological pharmaceuticals for Phase I and Phase II clinical trials.

Symbiosis Pharmaceutical Services, +44 1786 220000, enquiries@symbiosis-pharma.com, www.symbiosis-pharma.com.